Biocon Biologics at AAO 2024: Uwe Gudat in an Invigorating Discussion with PharmaShots
Shots: At the American Academy of Ophthalmology (AAO 2024), Biocon Biologics...
Shots: At the American Academy of Ophthalmology (AAO 2024), Biocon Biologics...
Shots: SLE-related diseases like CLE and IIM are characterized b...
Shots: A UK observational study spanning 17 years shows a 2.9-fold inc...
Shots: Biogen recently shared findings from the P-II/III DEVOTE study,...
Shots: Misfolded TTR can lead to chronic conditions like ATTRv-PN or A...
Shots: Johnson & Johnson’s (J&J) Tremfya recently received its third...
Incisive News in 3 Shots.
Modal body text goes here.